Question

Difficulty: MediumInterpreting Imaging Results

A 65-year-old man presents to the clinic for preoperative evaluation before an elective inguinal hernia repair. A screening posteroanterior and lateral chest radiograph reveals a 1.4-cm, well-circumscribed, non-calcified opacity in the peripheral right upper lobe. He has a 40-pack-year smoking history but quit 5 years ago. He is completely asymptomatic, reporting no cough, hemoptysis, shortness of breath, or weight loss. Physical examination is unremarkable. Arrange the following diagnostic steps in the most appropriate sequential order for the evaluation of this patient's imaging finding, from the initial action to the definitive diagnostic procedure.

  1. 1Procurement and review of prior chest radiographs or computed tomography scans
  2. 2Dedicated non-contrast thin-section computed tomography (CT) of the chest
  3. 3Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging
  4. 4Image-guided percutaneous transthoracic needle biopsy

Answer

The most appropriate step-wise sequence is to first review prior imaging, followed by a dedicated chest CT, a PET scan for metabolic assessment of the intermediate-risk lesion, and finally a biopsy for definitive tissue diagnosis.
The standard diagnostic algorithm for a newly discovered solitary pulmonary nodule prioritizes non-invasive, risk-stratifying steps before considering invasive procedures. Reviewing prior imaging is always the initial mandatory step to assess biological stability. If prior imaging is unavailable or the nodule is new, a dedicated non-contrast chest CT is performed to characterize anatomical features precisely. For solid nodules larger than 8 mm without definitively benign calcifications, FDG-PET is utilized to assess metabolic activity. Finally, lesions with highly suspicious morphological features or high avidity on PET undergo tissue biopsy or surgical excision for a definitive histopathological diagnosis.

Step-by-Step Solution

1
Procurement and review of prior chest radiographs or computed tomography scans
Establishes a timeline for the nodule's growth rate.
Comparing current findings with older studies is the most cost-effective and safest method to determine if a pulmonary nodule is benign (stable for >2 years) or potentially malignant.
2
Dedicated non-contrast thin-section computed tomography (CT) of the chest
Provides high-resolution anatomical detail of the nodule.
Required to evaluate the nodule's morphology, exact dimensions, and the presence of benign calcification patterns, which plain radiographs cannot adequately resolve.
3
Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging
Assesses the metabolic activity of the anatomical lesion.
Indicated for solid nodules >8 mm to differentiate between metabolically active (potentially malignant) and inactive (likely benign) lesions prior to invasive testing.
4
Image-guided percutaneous transthoracic needle biopsy
Yields cellular material for pathological review.
Provides a definitive tissue diagnosis for nodules that exhibit suspicious morphological features on CT or high metabolic avidity on PET imaging.

Key Concept

Algorithm for Evaluating a Solitary Pulmonary Nodule
Rate this question